The Oxysterol 27-Hydroxycholesterol Increases Oxidative Stress and Regulate Nrf2 Signaling Pathway in Astrocyte Cells

Neurochemical Research

Volumn 40, Issue 4, 2015, Pages 758-766

  Ma, Wei Wei ^a   Li, Chao Qun ^a   Yu, Huan Ling ^a   Zhang, Dan Di ^a   Xi, Yuan Di ^a   Han, Jing ^a   Liu, Quan Ri ^a   Xiao, Rong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

27 Hydroxycholesterol; C6 cells; Cholesterol; Nuclear factor E2 related factor 2; Oxidative damage

Indexed keywords

27-HYDROXYCHOLESTEROL; 8-OXO-7-HYDRODEOXYGUANOSINE; CHOLESTEROL DERIVATIVE; DEOXYGUANOSINE; NFE2L2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR NRF2;

ANALOGS AND DERIVATIVES; ASTROCYTE; DRUG EFFECTS; HUMAN; METABOLISM; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ASTROCYTES; CELL LINE, TUMOR; DEOXYGUANOSINE; HUMANS; HYDROXYCHOLESTEROLS; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 84940000134     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-015-1524-2     Document Type: Article

References (42)

1. Orth M, Bellosta S (2012) Cholesterol: its regulation and role in central nervous. Cholesterol 2012:292598
2. Cohen JI, Cazettes F, Convit A (2011) Abnormal cholesterol is associated with prefrontal white matter abnormalities among obese adults: a diffusion tensor imaging study. Neuroradiol J 1:989–997
3. Pfrieger FW, Ungerer N (2011) Cholesterol metabolism in neurons and astrocytes. Prog Lipid Res 50:357–371
4. Phillips EC, Croft CL, Kurbatskaya K, O’Neill MJ, Hutton ML, Hanger DP, Garwood CJ, Noble W (2014) Astrocytes and neuroinflammation in Alzheimer’s disease. Biochem Soc Trans 42:1321–1325
5. Marwarha G, Ghribi O (2014) Does the oxysterol 27-hydroxycholesterol underlie alzheimer’s disease—Parkinson’s disease overlap? Exp Gerontol. doi:10.1016/j.exger.2014.09.013
6. Björkhem I, Cedazo-Minguez A, Leoni V, Meaney S (2009) Oxysterols and neurodegenerative diseases. Mol Asp Med 30:171–179
7. Phan HT, Hata T, Morita M, Yoda T, Hamada T, Vestergaard MC, Takagi M (2013) The effect of oxysterols on the interaction of alzheimer’s amyloid beta with model membranes. Biochem Biophys Acta 1828:2487–2495
8. Ghribi O, Larsen B, Schrag M, Herman MM (2006) High cholesterol content in neurons increases BACE, beta-amyloid, and phosphorylated tau levels in rabbit hippocampus. Exp Neurol 200:460–467
9. Lesne SE (2014) Toxic oligomer species of amyloid-β in alzheimer’s disease, a timing issue. Swiss Med Wkly 144:w14021
10. Martín MG, Pfrieger F, Dotti CG (2014) Cholesterol in brain disease: sometimes determinant and frequently implicated. EMBO Rep 15:1036–1052
11. Gosselet F, Saint-Pol J, Fenart L (2014) Effects of oxysterols on the blood-brain barrier: implications for alzheimer’s disease. Biochem Biophys Res Commun 446:687–691
12. Milagre I, Olin M, Nunes MJ, Moutinho M, Lövgren-Sandblom A, Gama MJ, Björkhem I, Rodrigues E (2012) Marked change in the balance between CYP27A1 and CYP46A1 mediated elimination of cholesterol during differentiation of human neuronal cells. Neurochem Int 60:192–198
13. Ohtsuki S, Ito S, Matsuda A, Hori S, Abe T, Terasaki T (2007) Brain-to-blood elimination of 24S-hydroxycholesterol from rat brain is mediated by organic anion transporting polypeptide 2 (oatp2) at the blood-brain barrier. J Neurochem 103:1430–1438
14. Heverin M, Bogdanovic N, Lütjohann D, Bayer T, Pikuleva I, Bretillon L, Diczfalusy U, Winblad B, Björkhem I (2004) Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer’s disease. J Lipid Res 45:186–193
15. Vejux A, Malvitte L, Lizard G (2008) Side effects of oxysterols: cytotoxicity, oxidation, inflammation, and phospholipidosis. Braz J Med Biol Res 41:545–556
16. Joffre C, Leclère L, Buteau B, Martine L, Cabaret S, Malvitte L, Acar N, Lizard G, Bron A, Creuzot-Garcher C, Bretillon L (2007) Oxysterols induced inflammation and oxidation in primary porcine retinal pigment epithelial cells. Curr Eye Res 32:271–280
17. Shafaati M, Marutle A, Pettersson H, Lövgren-Sandblom A, Olin M, Pikuleva I, Winblad B, Nordberg A, Björkhem I (2011) Marked accumulation of 27-hydroxycholesterol in the brains of Alzheimer’s patients with the Swedish APP 670/671 mutation. J Lipid Res 52:1004–1010
18. Dasari B, Prasanthi JR, Marwarha G, Singh BB, Ghribi O (2010) The oxysterol 27-hydroxycholesterol increases β-amyloid and oxidative stress in retinal pigment epithelial cells. BMC Opthalmology 10:1–12
19. Famer D, Meaney S, Mousavi M, Nordberg A, Björkhem I, Crisby M (2007) Regulation of alpha-and beta-secretase activity by oxysterols: cerebrosterol stimulates processing of APP via the alpha-secretase pathway. Biochem Biophys Res Commun 359:46–50
20. Brown J 3rd, Theisler C, Silberman S, Magnuson D, Gottardi-Littell N, Lee JM, Yager D, Crowley J, Sambamurti K, Rahman MM, Reiss AB, Eckman CB, Wolozin B (2004) Differential expression of cholesterol hydroxylases in Alzheimer’s disease. J Biol Chem 279:34674–34681
21. Gamba P, Testa G, Sottero B, Gargiulo S, Poli G, Leonarduzzi G (2009) The link between altered cholesterol metabolism and Alzheimer’s disease. Ann NY Acad Sci 1259:54–64
22. Morris MC (2009) The role of nutrition in Alzheimer’s disease: epidemiological evidence. Eur J Neurol 16(Suppl 1):1–7
23. Sparks DL, Kuo YM, Roher A, Martin T, Lukas RJ (2000) Alterations of Alzheimer’s disease in the cholesterol-fed rabbit, including vascular inflammation. Ann NY Acad Sci 903:335–344
24. Chen J, Zhang X, Kusumo H, Costa LG, Guizzetti M (2013) Cholesterol efflux is differentially regulated in neurons and astrocytes: implications for brain cholesterol homeostasis. Biochem Biophys Acta 1831:263–275
25. Zwingmann C, Leibfritz D, Hazell AS (2003) Energy metabolism in astrocytes and neurons treated with manganese: relation among cell-specific energy failure, glucose metabolism, and intercellular trafficking using multinuclear NMR-spectroscopic analysis. J Cereb Blood Flow Metab 23:756–771
26. Leoni V, Caccia C (2011) Oxysterols as biomarkers in neurodegenerative diseases. Chem Phys Lipids 164:515–524
27. Xi YD, Yu HL, Ma WW, Ding BJ, Ding J, Yuan LH, Feng JF, Xiao R (2011) Genistein inhibits mitochondrial-targeted oxidative damage induced by beta-amyloid peptide 25-35 in PC12 cells. J Bioenerg Biomembr 43:399–407
28. Ma WW, Hou CC, Zhou X, Yu HL, Xi YD, Ding J, Zhao X, Xiao R (2013) Genistein alleviates the mitochondriatargeted DNA damage induced by β-amyloid peptides 25–35 in C6 glioma cells. Neurochem Res 38:1315–1323
29. Azad GK, Singh V, Mandal P, Singh P, Golla U, Baranwal S, Chauhan S, Tomar RS (2014) Ebselen induces reactive oxygen species (ROS)-mediated cytotoxicity in Saccharomyces cerevisiae with inhibition of glutamate dehydrogenase being a target. FEBS Open Bio 4:77–89
30. Valavanidis A, Vlachogianni T, Fiotakis C (2009) 8-hydroxy-2′-deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 27:120–139
31. Huang MC, Chen CC, Pan CH, Chen CH (2014) Comparison of oxidative DNA damage between alcohol-dependent patients with and without delirium tremens. Alcohol Clin Exp Res 38:2523–2528
32. Joshi G, Gan KA, Johnson DA, Johnson JA (2014) Increased Alzheimer’s disease-like pathology in the APP/PS1ΔE9 mouse model lacking Nrf2 through modulation of autophagy. Neurobiol Aging. doi:10.1016/j.neurobiolaging.2014.09.004
33. Ma WW, Yu HL, Yu HL, Ding BJ, Xi YD, Feng JF, Xiao R (2010) Genistein as a neuroprotective antioxidant attenuates redox imbalance induced by beta-amyloid peptides 25–35 in PC12 cells. Inter J Dev Neurosci 28(4):289–295
34. Ding J, Yu HL, Ma WW, Xi YD, Zhao X, Yuan LH, Feng JF, Xiao R (2013) Soy isoflavone attenuates brain mitochondrial oxidative stress induced by beta-amyloid peptides 1-42 injection in lateral cerebral ventricle. J Neurosci Res 91:562–567
35. Vomhof-Dekrey EE, Picklo MJ (2012) The Nrf2-antioxidant response element pathway: a target for regulating energy metabolism. J Nutr Biochem 23:1201–1206
36. Wang S, Zheng W, Liu X, Xue P, Jiang S, Lu D, Zhang Q, He G, Pi J, Andersen M, Tan H, Qu W (2014) Iodoacetic acid activates Nrf2-mediated antioxidant response in vitro and in vivo. Environ Sci Technol 48:13478–13488
37. Nguyen T, Nioi P, Pickett CB (2009) The Nrf2-antioxidant response element signaling pathway and its activation by oxidative Stress. J Biol Chem 284(20):13291–13295
38. Son Y, Lee JH, Chung HT, Pae HO (2013) Therapeutic roles of heme oxygenase-1 in metabolic diseases: curcumin and resveratrol analogues as possible inducers of heme oxygenase-1. Oxid Med Cell Longev 2013:1–8
39. Ryu MJ, Kang KA, Piao MJ, Kim KC, Zheng J, Yao CW, Cha JW, Chung HS, Kim SC, Jung E, Park D, Chae S, Hyun JW (2014) 7,8-Dihydroxyflavone protects human keratinocytes against oxidative stress-induced cell damage via the ERK and PI3K/Akt-mediated Nrf2/HO-1 signaling pathways. Int J Mol Med 33:964–970
40. Li L, Du JK, Zou LY, Wu T, Lee YW, Kim YH (2013) Decursin Isolated from Angelica gigas Nakai Rescues PC12 Cells from Amyloid β-Protein-Induced Neurotoxicity through Nrf2-Mediated Upregulation of Heme Oxygenase-1: potential Roles of MAPK. Evid Based Complement Altern Med 2013:1–14
41. Vaya J, Song W, Khatib S, Geng G, Schipper HM (2007) Effects of heme oxygenase-1 expression on sterol homeostasis in rat astroglia. Free Radic Biol Med 42:864–871
42. Hascalovici JR, Song W, Liberman A, Vaya J, Khatib S, Holcroft C, Laferla F, Schipper HM (2014) Neural HO-1/sterol interactions in vivo: implications for Alzheimer’s disease. Neuroscience 280C:40–49